A
Ad Atomica operates a closed-loop, AI-powered drug discovery system that integrates computational design with experimental validation. This platform rapidly transforms target identification into validated lead candidates by simultaneously optimizing for drug likeness, ADMET properties, and target affinity. The continuous learning cycle accelerates the path to clinic by designing highly optimized molecules in weeks, significantly reducing traditional development timelines and costs.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ad Atomica operates a closed-loop, AI-powered drug discovery system that integrates computational design with experimental validation. This platform rapidly transforms target identification into validated lead candidates by simultaneously optimizing for drug likeness, ADMET properties, and target affinity. The continuous learning cycle accelerates the path to clinic by designing highly optimized molecules in weeks, significantly reducing traditional development timelines and costs.